Company intelligence
Inhalation Sciences Sweden AB
More Predictive Power in Pharmacokinetics
About Inhalation Sciences Sweden AB
Inhalation Sciences is a Swedish, cutting-edge CRO specializing in inhaled drug development for IND's, generics, and biologics. Our services enable data-driven decision-making early in development, helping minimize risk, reduce timelines, and lower costs. Unique deliverables enabled by our proprietary PreciseInhale® technology platform; • Precision dosing of aerosol • Unmatched precision in pharmacokinetic data - correlating to in-human results • Unprecedented clinical predictability • Significantly de-risking inhaled drug development • Reduced use of API and animals Our multidisciplinary team brings extensive contract research experience in inhalation drug development. Our founder and CSO, Per Gerde is a recognized world authority and Associate Professor of Inhalation Toxicology at the Institute of Environmental Medicine, Karolinska Institute in Sweden. Visit our website: http://www.inhalation.se/ Visit our labs: Kliniskt Forskningscentrum KFC Novum plan 6 hiss A Hälsovägen 7 141 57 Huddinge, Sweden Visitor entrance, Blickagången 6, elevator E, level 6
Verified activity
Signals from Inhalation Sciences Sweden AB
2 published signals
Products & Services
Inhalation Sciences Sweden AB introduced XposeALI® exposure module and PreciseInhale® for biologics preclinical testing.
Reported by Inhalation Sciences Sweden AB
Presence & Recognition
Inhalation Sciences Sweden AB will attend the Exploring the Future of Inhalation Drug Delivery 2026 conference in Parma, Italy.
Reported by Inhalation Sciences Sweden AB